SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sugen (SUGN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LLCF who wrote (368)4/5/1999 10:52:00 AM
From: Mike K  Read Replies (1) of 550
 
David; I like and own both. I have a small position in CELG stock
and have sold 50 put contracts at various prices and expiry dates. I have a somewhat larger position in SUGN and have also sold May 17 1/2
puts.

Looking at selling more SUGN puts today. With all the hype of the last
week, premiums are much more attractive.

BTW, I am a multiple myeloma patient, who looking at both companies
very closely. My illness is very early stage and I am currently enrolled in a phase 1 gene therapy trial. Thalidomide is a drug that
I will definitely consider down the road. SUGN is also conducting a
phase 1 trial of SU5416 which includes multiple myeloma patients at Royal Marsden Hospital in London and the Arizona Cancer Center.

Cheers,

Mike
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News